InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by AZAB MOHAMMAD, Director. Insider active across 2 companies, notably Xenon Pharmaceuticals Inc.. Cumulatively, 4 reports have been recorded. Total volume traded: €5k. The latest transaction was disclosed on 24 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations4 total
€1,8285,000 shares@ €0.365633.6% of flow
Common Stock
SEC:0001209191-22-031997:0·
Ideal exit: 18 Feb 2023 (T+270)
€3,60910,000 shares@ €0.360966.4% of flow
Common Stock
SEC:0001209191-22-030276:0·
Ideal exit: 10 Feb 2023 (T+270)
€10,0573,086 shares@ €3.2590.0002% mcap100.0% of flow
Common Shares
SEC:0001209191-21-070231·
€10,0573,086 shares@ €3.2590.0002% mcap50.0% of flow
Common Shares
SEC:0001209191-21-070231:0·
4 of 4 declarations
About AZAB MOHAMMAD
Mohammad Azab is a Director at Xenon Pharmaceuticals Inc. and Durect Corp, companies specializing in the biopharmaceutical sector. In this role, he participates in the governance of these companies and strategic decision-making. His experience in the sector allows him to provide valuable insights into growth opportunities and market challenges.
